Skip to content

Proxcelan™ Cs-131 Brachytherapy SeedsRecalls & reported problems

Isoray Medical, Inc. · Class 2 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI M748CS10), received between Nov 6, 2019 and Nov 6, 2019 — classified as 1 injury.

The most frequently reported specific device problem is “Patient-Device Incompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Patient-Device Incompatibility1

Patient problems

  • Inflammation1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryNov 6, 2019Patient-Device Incompatibility

    DURING A CUSTOMER SERVICE FOLLOW-UP WITH THE FACILITY, 22 DAYS POST IMPLANT, ISORAY WAS NOTIFIED THAT THE PATIENT "GOT PROCTITIS AND A COLORECTAL SURGEON DIVERTED HER WITH A COLOSTOMY." WHILE CLARIFYING IF THE ISSUE HAD CONNECTION TO THE IMPLANT, THE FACILITY SUGGESTED THAT THE TEMPORAL COURSE OF THE COMPLICATION SUGGESTS THAT THE IMPLANT WAS ASSOCIATED WITH THE DEVELOPMENT OF THE ADVERSE EVENT.

    Patient problems: Inflammation

    MAUDE report 9284730 ↗

Other Source, Brachytherapy, Radionuclide devices

All Source, Brachytherapy, Radionuclide devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page